Literature DB >> 11081831

Masculine copulatory behavior is facilitated by intrathecally administered muscarine.

I Durán1, L Gil, R Cueva-Rolón.   

Abstract

Behavioral experiments were conducted to examine the role of the cholinergic receptor-agonist muscarine or its antagonist homatropine on the mating behavior of sexually experienced male rats. Male copulatory behavior was recorded after intrathecally administered saline, muscarine (7.5 microg), or homatropine (25 microg). Changes in copulatory behavior were assessed by the following parameters: intromission latency, intromission frequency, intercopulatory interval, ejaculation latency, and postejaculatory interval. Intromission frequency, intercopulatory interval, and ejaculation latency were decreased significantly by muscarine. Intrathecal homatropine decreased the number of copulating animals (five out of 13). In the five animals that were able to ejaculate after homatropine, intromission latency, intercopulatory interval, and ejaculation latency increased significantly. The effects of both drugs on locomotion were also tested. Muscarine induced no significant changes in locomotion compared with saline. A significant increase in locomotion was found after homatropine treatment. These results suggest that acetylcholine, acting at spinal-cord muscarinic receptors, may be involved in ejaculation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11081831     DOI: 10.1007/s002210000488

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  2 in total

Review 1.  Preclinical evidence supporting the clinical development of central pattern generator-modulating therapies for chronic spinal cord-injured patients.

Authors:  Pierre A Guertin
Journal:  Front Hum Neurosci       Date:  2014-05-30       Impact factor: 3.169

Review 2.  The drug treatment of delayed ejaculation.

Authors:  Ibrahim A Abdel-Hamid; Moustafa A Elsaied; Taymour Mostafa
Journal:  Transl Androl Urol       Date:  2016-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.